MoveMed is redefining how outcomes are measured in clinical trials. This patented approach enables much smaller, faster and cost-effective trials without compromising scientific rigor, unlocking the key bottleneck in drug discovery.
To develop a drug successfully, it's crucial to demonstrate real patient benefit. Patient-reported outcomes (PROs) are the gold standard but require large sample sizes and may miss key effects, leading to false negatives.
That's why early studies often use biomarkers, though these can also fail to capture the patient experience, potentially leading to false positives.
MoveMed’s breakthrough is to offer both.
Our method allows us to avoid false dawns and missed opportunities. Through its mobile application MoveMed encourages patients to complete and interpret digital performance measures, preserving the patient’s “voice” while delivering the statistical power of a biomarker:
Our tests directly assess patient experience; the patient voice - we are not measuring a surrogate of this (e.g. a blood test). Completed remotely and at their convenience, this provides real-life measurement even if a disease is variable.
With assessments covering multiple features (e.g., hand and leg function), we gather a comprehensive insight, and ensure even if one area shows limited change, gains in another are identified.
Digital assessments encourage completion, and centralized monitoring enables direct patient engagement to ensure compliance. This minimizes missing data, supporting consistent and reliable results.
Frequent testing allows results to be averaged, reducing the impact of outliers or single erroneous readings. With built-in quality checks, MoveMed ensures patient data is accurate, complete, and reliable—addressing common PRO challenges.
Our assessments are granular and reliable, offering far greater statistical power. This reduces the patient numbers needed for reliable results—either as a primary outcome, or a powerful tool for patient stratification to identify treatment responders.
Available globally on both Apple and Android devices,
and in multiple languages, expanding eligibility and accessibility for diverse patient populations.
Integrates with operating system health measures
like Google Fit and Apple HealthKit for enriched data collection.
Allows deployment of custom electronic PROs
to capture tailored patient-reported outcomes.
Provides a real-time dashboard
for monitoring recruitment progress and data compliance, ensuring a smooth and reliable trial experience.
MoveMed enabled us to assess end-points remotely and helped with patient engagement. Of course, PerfOMs have significant potential, and I am excited to see the outcome of a direct comparison with a clinical gold standard. The gamified assessments helped with patient engagement and verbally patients supported the use of the app and liked the feedback given. The smartphone-based approach was convenient for patients and researchers.
MoveMed is a great tool to use for research. The interface was easy to navigate and made data collection simple. The exported MoveMed data contained relevant outcome measures crucial for data analysis. It was a great experience using MoveMed and would highly recommend it to all researchers!
The app made it incredibly convenient to contribute to Myelopathy research from the comfort of my home. The assessments felt like playing a game, which kept me engaged and motivated to continue over time. It was a great feeling to know that my data could potentially contribute to advancing research.
MoveMed enabled us to assess end-points remotely and helped with patient engagement. Of course, PerfOMs have significant potential, and I am excited to see the outcome of a direct comparison with a clinical gold standard. The gamified assessments helped with patient engagement and verbally patients supported the use of the app and liked the feedback given. The smartphone-based approach was convenient for patients and researchers.
MoveMed is a great tool to use for research. The interface was easy to navigate and made data collection simple. The exported MoveMed data contained relevant outcome measures crucial for data analysis. It was a great experience using MoveMed and would highly recommend it to all researchers!
The app made it incredibly convenient to contribute to Myelopathy research from the comfort of my home. The assessments felt like playing a game, which kept me engaged and motivated to continue over time. It was a great feeling to know that my data could potentially contribute to advancing research.
Find out how our product will improve your research